335 related articles for article (PubMed ID: 21595653)
21. The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.
Scherma M; Justinová Z; Zanettini C; Panlilio LV; Mascia P; Fadda P; Fratta W; Makriyannis A; Vadivel SK; Gamaleddin I; Le Foll B; Goldberg SR
Br J Pharmacol; 2012 Apr; 165(8):2539-48. PubMed ID: 21557729
[TBL] [Abstract][Full Text] [Related]
22. Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.
Rimmerman N; Bradshaw HB; Kozela E; Levy R; Juknat A; Vogel Z
Br J Pharmacol; 2012 Apr; 165(8):2436-49. PubMed ID: 21449981
[TBL] [Abstract][Full Text] [Related]
23. N-arachidonoyl glycine, another endogenous agonist of GPR55.
Console-Bram L; Ciuciu SM; Zhao P; Zipkin RE; Brailoiu E; Abood ME
Biochem Biophys Res Commun; 2017 Sep; 490(4):1389-1393. PubMed ID: 28698140
[TBL] [Abstract][Full Text] [Related]
24. GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine.
Finlay DB; Joseph WR; Grimsey NL; Glass M
PeerJ; 2016; 4():e1835. PubMed ID: 27018161
[TBL] [Abstract][Full Text] [Related]
25. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
[TBL] [Abstract][Full Text] [Related]
26. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
27. Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18.
McHugh D; Roskowski D; Xie S; Bradshaw HB
Front Pharmacol; 2014; 4():162. PubMed ID: 24427137
[TBL] [Abstract][Full Text] [Related]
28. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors.
Hejazi N; Zhou C; Oz M; Sun H; Ye JH; Zhang L
Mol Pharmacol; 2006 Mar; 69(3):991-7. PubMed ID: 16332990
[TBL] [Abstract][Full Text] [Related]
29. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
30. Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18.
Neumann A; Engel V; Mahardhika AB; Schoeder CT; Namasivayam V; Kieć-Kononowicz K; Müller CE
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365486
[TBL] [Abstract][Full Text] [Related]
31. N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels.
Parmar N; Ho WS
Br J Pharmacol; 2010 Jun; 160(3):594-603. PubMed ID: 20136843
[TBL] [Abstract][Full Text] [Related]
32. RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB
Glenn NAK; Finlay DB; Carruthers ER; Mountjoy KG; Walker CS; Grimsey NL
Br J Pharmacol; 2024 Jul; 181(14):2212-2231. PubMed ID: 37085333
[TBL] [Abstract][Full Text] [Related]
33. The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors.
Baur R; Gertsch J; Sigel E
Br J Pharmacol; 2012 Apr; 165(8):2479-84. PubMed ID: 21470203
[TBL] [Abstract][Full Text] [Related]
34. AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.
Bolognini D; Cascio MG; Parolaro D; Pertwee RG
Br J Pharmacol; 2012 Apr; 165(8):2561-74. PubMed ID: 21615724
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.
Dalton GD; Howlett AC
Br J Pharmacol; 2012 Apr; 165(8):2497-511. PubMed ID: 21518335
[TBL] [Abstract][Full Text] [Related]
36. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M
Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
McMahon LR; Ginsburg BC; Lamb RJ
Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoids and the human uterus during pregnancy.
Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
40. Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders.
Frankowska M; Wydra K; Suder A; Zaniewska M; Gawliński D; Miszkiel J; Furgała-Wojas A; Sałat K; Filip M; Müller CE; Kieć-Kononowicz K; Kotańska M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
